SML synlait milk limited

Ann: FLLYR: SML: Synlait Milk posts $19.6 million NPAT for FY2014

  1. lightbulb Created with Sketch. 2
    • Release Date: 22/09/14 08:39
    • Summary: FLLYR: SML: Synlait Milk posts $19.6 million NPAT for FY2014
    • Price Sensitive: No
    • Download Document  4.77KB
    					SML
    22/09/2014 08:39
    FLLYR
    
    REL: 0839 HRS Synlait Milk Limited (NS)
    
    FLLYR: SML: Synlait Milk posts $19.6 million NPAT for FY2014
    
    Synlait Milk has posted a $19.6 million net profit after tax (NPAT) for the
    year ending 31 July 2014, an increase of 70% compared to the $11.5 million
    NPAT for FY2013, and in line with its prospective financial information (PFI)
    forecast of $19.7 million.
    
    Revenue was $600 million in FY2014, an increase of 43% compared to $420
    million for FY2013, and well ahead of the PFI forecast of $524 million.
    
    Synlait Milk Chairman Graeme Milne said he is pleased with the result and the
    continued growth of the business in its sixth year of operation.
    
    "Our focus during the year has been to deliver on the promises we made to
    shareholders when we listed on the New Zealand Stock Exchange in 2013.
    Profitability was on target with our PFI, driven largely by a favourable
    product mix that enabled the business to make the most from the period of
    very high world market prices.
    
    "However, achieving targeted premiums and gross margin for specialised
    ingredients when world market prices were high proved challenging. Along with
    the development of our nutritionals business being set back by regulatory
    change in the important Chinese market, it meant the profitability advantages
    over and above PFI we experienced in the first half of the year were largely
    eliminated.
    
    "Over what has been a challenging year, the progress we have made with our
    key customers continues to give us confidence in our future. The ongoing
    execution of our growth initiatives to ensure the development of our infant
    formula and nutritionals business supports these customers is a key focus
    going forward," said Mr Milne.
    
    Synlait Milk's growth initiatives, including a 22,500m2 drystore expansion,
    lactoferrin extraction and purification plant and blending and consumer
    packaging plant were completed during the year.
    
    Construction has begun on a new administration office and quality assurance
    laboratory, as well as a third large scale infant formula capable dryer, due
    to be completed in September 2015.
    
    (see PDF for key metrics table)
    
    Synlait Milk's volume of milk grew to 49.9 million kilograms of milk solids
    (kgMS) in FY2014, lifting manufactured volumes to 96,492 metric tonnes (MT).
    This compares to a volume of milk of 46.8 million kgMS and manufactured
    volumes of 91,229 MT in FY2013.
    
    Synlait Milk paid its milk suppliers a total average milk price of $8.31 per
    kg MS.
    
    Managing Director Dr John Penno said the focus for the coming financial year
    will be on the execution of the current growth initiatives, maximising volume
    growth of the infant formula and nutritionals business and ensuring
    operational targets are achieved.
    
    "We continue to invest in people, systems, plant and equipment to build
    technical capability that supports our strategic development," said Dr Penno.
    
    "Our customer and market development strategy is progressing faster than we
    planned. We now produce product for four of the world's leading multinational
    infant formula companies and are in discussions with each of them about
    increasing volumes, manufacturing higher value products and collaborating on
    research and development opportunities."
    
    "China remains an important focus for us. The disruption caused during the
    year by the regulatory changes is easing and we are well positioned to take
    advantage of improved returns from increased sales in this market."
    
    "It is our desire, as the manufacturing company, to develop a close
    association with our Chinese brand owners to reassure consumers that these
    brands are produced from a reliable, vertically integrated company that is
    prepared to stand behind the quality of the product. This approach has been
    signalled by Chinese officials as a future requirement for the export of
    retail-ready infant formula to China."
    
    "We are pleased to announce we have entered into a conditional agreement,
    subject to certain approvals, for a 25% shareholding in Sichuan New Hope
    Nutritional Foods Co., Ltd., the company responsible for the ownership, sale
    and distribution of the akaraTM branded infant formula range in China.
    Through a small investment, the partnership will create an integrated supply
    chain for the manufacture, packaging, supply, distribution and sale of
    akaraTM to consumers in China, ensuring transparency back from can to
    paddock," said Dr Penno.
    
    In FY2014 Synlait Milk achieved a pre-tax return on capital employed of
    11.5%.
    
    In relation to its dividend policy, Synlait Milk confirmed that with its
    present focus firmly on growing the business, no dividend will be payable for
    the financial year ending 31 July 2014, nor for the immediate future. This is
    consistent with statements made in the Investment Statement and Prospectus at
    the time of listing.
    End CA:00255491 For:SML    Type:FLLYR      Time:2014-09-22 08:39:38
    				
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.